These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 29772480)
21. Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis. Wen G; An W; Chen J; Maguire EM; Chen Q; Yang F; Pearce SWA; Kyriakides M; Zhang L; Ye S; Nourshargh S; Xiao Q J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437605 [TBL] [Abstract][Full Text] [Related]
22. Effects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1. Meurs I; Calpe-Berdiel L; Habets KL; Zhao Y; Korporaal SJ; Mommaas AM; Josselin E; Hildebrand RB; Ye D; Out R; Kuiper J; Van Berkel TJ; Chimini G; Van Eck M PLoS One; 2012; 7(3):e30984. PubMed ID: 22403608 [TBL] [Abstract][Full Text] [Related]
23. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413 [TBL] [Abstract][Full Text] [Related]
24. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice. Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974 [TBL] [Abstract][Full Text] [Related]
25. HDL is essential for atherosclerotic lesion regression in Apoe knockout mice by bone marrow Apoe reconstitution. van der Sluis RJ; Verwilligen RAF; Lendvai Z; Wever R; Hoekstra M; Van Eck M Atherosclerosis; 2018 Nov; 278():240-249. PubMed ID: 30340108 [TBL] [Abstract][Full Text] [Related]
27. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice. van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138 [TBL] [Abstract][Full Text] [Related]
28. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report. van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375 [TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function. Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878 [TBL] [Abstract][Full Text] [Related]
30. Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression. Li Y; Jiang B; Liang P; Tong Z; Liu M; Lv Q; Liu Y; Liu X; Tang Y; Xiao X Biochem Biophys Res Commun; 2017 Apr; 486(2):364-371. PubMed ID: 28315324 [TBL] [Abstract][Full Text] [Related]
31. Bone marrow angiotensin AT2 receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions. Kato T; Kawahito H; Kishida S; Irie D; Wakana N; Kikai M; Takata H; Ogata T; Ueyama T; Matoba S; Yamada H J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):936-46. PubMed ID: 25487979 [TBL] [Abstract][Full Text] [Related]
32. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345 [No Abstract] [Full Text] [Related]
33. CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice. Wang XQ; Wan HQ; Wei XJ; Zhang Y; Qu P Mol Med Rep; 2016 Jul; 14(1):49-56. PubMed ID: 27176130 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735 [TBL] [Abstract][Full Text] [Related]
35. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice. Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450 [TBL] [Abstract][Full Text] [Related]
36. Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development. Lammers B; Out R; Hildebrand RB; Quinn CM; Williamson D; Hoekstra M; Meurs I; Van Berkel TJ; Jessup W; Van Eck M Atherosclerosis; 2009 Aug; 205(2):420-6. PubMed ID: 19217108 [TBL] [Abstract][Full Text] [Related]
37. Astragalin Retards Atherosclerosis by Promoting Cholesterol Efflux and Inhibiting the Inflammatory Response via Upregulating ABCA1 and ABCG1 Expression in Macrophages. Zhao ZW; Zhang M; Wang G; Zou J; Gao JH; Zhou L; Wan XJ; Zhang DW; Yu XH; Tang CK J Cardiovasc Pharmacol; 2021 Feb; 77(2):217-227. PubMed ID: 33165140 [TBL] [Abstract][Full Text] [Related]
38. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice. Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917 [TBL] [Abstract][Full Text] [Related]
39. CCN3 Regulates Macrophage Foam Cell Formation and Atherosclerosis. Shi H; Zhang C; Pasupuleti V; Hu X; Prosdocimo DA; Wu W; Qing Y; Wu S; Mohammad H; Gerson SL; Perbal B; Klenotic PA; Dong N; Lin Z Am J Pathol; 2017 Jun; 187(6):1230-1237. PubMed ID: 28527710 [TBL] [Abstract][Full Text] [Related]
40. Macrophage Lxrα reduces atherosclerosis in Ldlr Yin Y; Zeng S; Li Y; Wu Z; Huang D; Gao P Biochem Biophys Res Commun; 2020 Aug; 529(3):540-547. PubMed ID: 32736671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]